Is quite complex. The fda ensures that any vaccine going into clinical studies is. Afe ultimately it goes through the approval process. This is why we have such a reduction in childhood illness, we can count on the safety of the vaccines. And even after they are approved , they can be monitored for safety. To specific scientists work directly with these medical companies throughout the process . Is it a team effort . There is a particular center, the center for biologics and the office of vaccines research. Those are experts on the whole range of issues around vaccines, from their chemistry to manufacturing and clinical trials. They have review teams with these different scientific disciplines. They interact a lot with manufacturers during the process. When it comes to, you are on the board of glaxosmithkline as head of the Science Committee. Can you talk about what that entails. Guest on the Science Committee we work at opportunities to. Evelop new products host are you personally inv
Chief scientist of the food and Drug Administration serving from 20092014. Oodman, good morning. As you talk about your work chief scientist and how it relates to the fdas role with finding a vaccine . The science of vaccines is very complex. They are complex the study. On thentry relies experts at the fda to ensure that any vaccine that goes into clinical studies and oversees the Development Process and ultimately the approval process. Have such ane amazing reduction in childhood illness. Approved, itey are is monitoring their safety. To particular scientists work directly with the companies or is it a team effort . How does that work . There is an office called the office of Vaccine Research and there are experts on a whole range of issues from their chemistry, their manufacturing, their trials. There are different scientific disciplines that interacted the process, but at the end, it is completely independent. Host when it comes to you personally, just to care five to out just to cl
The food and Drug Administration during the obama presidency. Moss from theliam Johns Hopkins Bloomberg School of Public Health talks about the global effort to develop a vaccine. Good morning, this is washington journal for september 10. In the first hour we will take your comments about bob woodward about the early assessments of coronavirus. The president saying that initially he wanted to play it down. If you want us to let us know your thoughts on this release of the audiotapes from yesterday and the reaction to it. If you support the president and Vice President call into 2027488000. If you support joe biden and kamala harris, 2027488001. If you are undecided or supporting others, 2027488002. You can text us your thoughts at 2027488003. Wj and postcspan on our Facebook Page at facebook. Com cspan. The Washington Post headline from one of the excerpts from the audio releases from yesterday, i always wanted to play it down. This is coming from Bob Woodwards book say book rage. This
Dr. Jesse goodman is joining us. Guest good morning. Host could you talk about, in a broad sense, your work at the fda . ,articularly as chief scientist particularly when it comes to vaccines. The science of vaccines is quite complex. The fda ensures that any vaccine going into clinical studies is. Afe ultimately it goes through the approval process. This is why we have such a reduction in childhood illness, we can count on the safety of the vaccines. And even after they are approved , they can be monitored for safety. To specific scientists work directly with these medical companies throughout the process . Is it a team effort . There is a particular center, the center for biologics and the office of vaccines research. Those are experts on the whole range of issues around vaccines, from their chemistry to manufacturing and clinical trials. They have review teams with these different scientific disciplines. They interact a lot with manufacturers during the process. When it comes to, yo
Buckeye broadband support cspan is a Public Service along these other Television Providers were giving a front row seat to democracy. Next, testimony on roadway safety before a Senate Commerce, science and transportation subcommittee. From transportation policy advocates and local officials. They discuss roadway fatalities, infrastructure needs, Pedestrian Safety and the integration of Autonomous Vehicles. This is an hour and 40 minutes. [background noises] the subcommittee will come to order. Today the subcommittee for surface transportation, maritime, freight imports will examine the roadway safety crisis. These solutions we must implement and responsive. Boots would like to thank my Ranking Member, senator young as well as chert cantwell and member crews for their help in convening this very important hearing. Every day unfortunately more than 100 americans lose their lives on our roads. If trends continue what we expect more than 40000 fatalities this year. Hundreds of thousands of